Plasma Proteomic Patterns Show Sex Differences in Early Concentric Left Ventricular Remodeling

Anne-Mar van Ommen1, Ernest Diez Benavente1, N Charlotte Onland-Moret2

  • 1Laboratory of Experimental Cardiology (A.-M.v.O., E.D.B., G.B.V., H.M.d.R.), University Medical Center Utrecht, Utrecht University, the Netherlands.

PubMed

Insights

Concentric remodeling (cRM) affects about 1 in 4 women and men, increasing heart failure with preserved ejection fraction (HFpEF) and mortality risk. Inflammatory pathways and IFNA5 are key in women, suggesting new therapeutic targets.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Proteomics

Background:

  • Concentric remodeling (cRM) is a precursor to heart failure with preserved ejection fraction (HFpEF).
  • HFpEF is notably prevalent in women.
  • Understanding cRM's development and risk factors is crucial for cardiovascular health, especially in women.

Purpose of the Study:

  • To investigate the prevalence of cRM in a large outpatient cardiology population.
  • To determine the association of cRM with HFpEF development and mortality.
  • To identify sex-specific risk factors and molecular pathways involved in cRM.

Main Methods:

  • Analysis of 60,593 patients from outpatient cardiology clinics for cRM, HFpEF, and mortality.
  • Sex-stratified analysis of risk factors for relative wall thickness.
  • Proteomic profiling of 4,534 plasma proteins in a 557-patient substudy to identify pathways involved in cRM.

Main Results:

  • cRM was found in 23.5% of women and 27.6% of men, linked to increased HFpEF risk (HR 2.15) and mortality (HR 1.09).
  • Risk factors for relative wall thickness were stronger in women.
  • Elevated IFNA5 levels and activated inflammatory pathways were observed in women with cRM.

Conclusions:

  • cRM is a common condition associated with adverse cardiovascular outcomes in both sexes.
  • Sex differences in risk factors and inflammatory pathway activation, particularly involving IFNA5 in women, may explain HFpEF's female predominance.
  • These findings offer potential for novel therapeutic strategies targeting cRM and HFpEF prevention and treatment.
Abstract